Page last updated: 2024-11-06

lysergic acid diethylamide and Adenocarcinoma, Basal Cell

lysergic acid diethylamide has been researched along with Adenocarcinoma, Basal Cell in 2 studies

Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.

Research Excerpts

ExcerptRelevanceReference
"Methysergide was also found to accelerate tumour cell proliferation, whereas cyproheptadine did not."1.26Evaluation of the cytotoxicity of dihydroxytryptamines and 5-hydroxytryptamine antagonists as cytotoxic agents in dimethylhydrazine-induced adenocarcinomata. ( Barkla, DH; Tutton, PJ, 1978)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SCOTT, KG1
DANIELS, AE1
Tutton, PJ1
Barkla, DH1

Other Studies

2 other studies available for lysergic acid diethylamide and Adenocarcinoma, Basal Cell

ArticleYear
THE SIMILAR ACTION OF LYSERGIC ACID DERIVATIVES, HYPERTENSIN (CIBA) AND ALDOSTERONE UPON RB86 UPTAKE BY RED BLOOD CELLS FROM CONTROL AND CANCER SUBJECTS.
    Proceedings of the Western Pharmacology Society, 1963, Volume: 6

    Topics: Adenocarcinoma; Aldosterone; Angiotensin Amide; Angiotensins; Carcinoma, Squamous Cell; Erythrocytes

1963
Evaluation of the cytotoxicity of dihydroxytryptamines and 5-hydroxytryptamine antagonists as cytotoxic agents in dimethylhydrazine-induced adenocarcinomata.
    Cancer chemotherapy and pharmacology, 1978, Volume: 1, Issue:4

    Topics: 5,6-Dihydroxytryptamine; 5,7-Dihydroxytryptamine; Adenocarcinoma; Animals; Antineoplastic Agents; Cy

1978